OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-050176
PubMed Identifier: 34824113
Publication URI: http://europepmc.org/abstract/MED/34824113
Type: Journal Article/Review
Volume: 11
Parent Publication: BMJ open
Issue: 11
ISSN: 2044-6055